Dr. Brian Mehling, MD
Dr. Brian Mehling, MD
Chief Medical Officer and Founder
Brian Mehling, M.D., M.S. is the founder and chief medical officer of Blue Horizon International (BHI). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He is spearheading groundbreaking research in stem cell therapy through his company, Blue Horizon International, a healthcare consulting organization focused on treatment and research using stem cells. He is board-certified by the American Board of Orthopaedic Surgeons and the American Board of Anti-Aging Medicine.
Dr. Mehling started his path in medicine through undergraduate study at Harvard University, obtaining his Bachelor of Arts and Master of Science degrees in Biochemistry from Ohio State University.
Completing his degree of medicine at Wright State University School of Medicine, Dr. Mehling received post graduate education through residencies and fellowships at St. Joseph’s Hospital in Paterson, NJ and the Graduate Hospital in Philadelphia, PA, while pursuing a Ph.D. in Chemistry.
An orthopedic trauma surgeon, Dr. Mehling operates his own practice, Mehling Orthopedics, in both West Islip, NY and Hackensack, NJ. He is also on call at Good Samaritan Hospital, Hackensack University Medical Center, Hackensack University Medical Center at Pascack Valley, St. Joseph’s Medical Center, and St. Joseph’s Wayne Medical Center.
Dr. Mehling has traveled extensively throughout Asia and the Middle East observing firsthand the differences in healthcare standards. Identifying the need for a universal high quality standard, he founded Blue Horizon International.
He and his colleagues have successfully treated and monitored more than 600 patients using stem cell and regenerative therapies. Patients have been treated for a wide range of diseases and disorders including spinal cord injury and cerebral palsy.
Dr. Mehling founded the Blue Horizon Charitable Foundation, which was with the mission to assist in and finance the advancement of all aspects of stem cell therapies and cellular regenerative medicine and research in full regulatory conformance, in conjunction with the scientific community. The foundation will also support and provide charitable therapies to those suffering from degenerative diseases and debilitating conditions.
Apart from his organizations, Dr. Mehling personally contributes his time and resources to charitable causes. He has sponsored patients’ trips to China for stem cell treatments, as well as hosting charitable events from his own homes in New York, the Hamptons, and France. Notable beneficiaries include The Sean Kimmerling Testicular Cancer Foundation and the Children of Chernobyl.
Dr. Mehling also raises awareness through his film company, Industrial Motion Pictures (IMP). His full feature documentary, “Tiny Tears,” presented at the Cannes and New York Film Festivals, is a collection of testimonials from caregivers and volunteers in different countries, devoted to saving and helping children affected by AIDS. He is currently working on several other film projects, among them a documentary exploring the future of medicine and revolution taking place in stem cell therapy.